Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 3
2007 8
2008 3
2009 5
2010 3
2011 4
2012 6
2013 8
2014 12
2015 8
2016 7
2017 11
2018 4
2019 9
2020 19
2021 31
2022 22
2023 27
2024 38
2025 50
2026 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Results by year

Filters applied: . Clear all
Page 1
Pan-cancer spatial atlas of tertiary lymphoid structures.
Cho KS, Liu Y, Pei G, Chen J, Dai Y, Liu Y, Zhou T, Bougouin A, Serrano A, Wani K, Jadhav A, Min J, Hernandez S, Lu W, Zhang D, Jiang J, Shamsutdinova D, Dai E, Peng F, Sinjab A, Guerrero PA, Julio ICL, Yu K, Clark H, Maru D, Li M, Futreal A, Lee S, Solis Soto LM, Shang L, Msaouel P, Ajani JA, Beird H, Jazaeri AA, Lazar AJ, Sautes-Fridman C, Fridman WH, Maitra A, Kadara H, Gao J, Sharma P, Wang L. Cho KS, et al. Among authors: msaouel p. Science. 2026 May 28;392(6801):eadz2742. doi: 10.1126/science.adz2742. Epub 2026 May 28. Science. 2026. PMID: 42207882
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.
Yu K, Chen J, Chu YY, Nair S, Crupi E, Hasanov E, Mei Y, Han X, Liu Y, Liu Y, Pei G, Peng F, Liao J, Dai E, Chu T, Cho KS, Jiang J, Yan X, Dai Y, Wang J, Zhang B, Genovese G, Putluri N, Eberlin L, Yang L, Lin C, Kwong LN, Shamsutdinova D, Wani KM, Czerniak BA, Yu W, Zhao J, Guo CC, Hansel D, Pettaway C, Pisters L, Bree K, Navai N, Lee BH, Kamat AM, Sharma P, Corn P, Jiang CY, Shah AY, Alhalabi O, Msaouel P, Siefker-Radtke AO, Logothetis CJ, Campbell MT, Lazar AJ, Gao J, Wang L. Yu K, et al. Among authors: msaouel p. Cancer Discov. 2026 May 13. doi: 10.1158/2159-8290.CD-26-0099. Online ahead of print. Cancer Discov. 2026. PMID: 42126225
Medicine before and after David Cox.
Msaouel P, Jimenez-Fonseca P, Lim B, Carmona-Bayonas A, Agnelli G. Msaouel P, et al. Eur J Intern Med. 2022 Apr;98:1-3. doi: 10.1016/j.ejim.2022.02.022. Epub 2022 Feb 28. Eur J Intern Med. 2022. PMID: 35241350 Free PMC article.
Interpreting Randomized Controlled Trials.
Msaouel P, Lee J, Thall PF. Msaouel P, et al. Cancers (Basel). 2023 Sep 22;15(19):4674. doi: 10.3390/cancers15194674. Cancers (Basel). 2023. PMID: 37835368 Free PMC article. Review.
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.
Amara CS, Kami Reddy KR, Yuntao Y, Chan YS, Piyarathna DWB, Dobrolecki LE, Shih DJH, Shi Z, Xu J, Huang S, Ellis MJ, Apolo AB, Ballester LY, Gao J, Hansel DE, Lotan Y, Hodges HC, Lerner SP, Creighton CJ, Sreekumar A, Zheng WJ, Msaouel P, Kavuri SM, Putluri N. Amara CS, et al. Among authors: msaouel p. Nat Commun. 2024 Feb 14;15(1):1373. doi: 10.1038/s41467-024-45132-2. Nat Commun. 2024. PMID: 38355560 Free PMC article.
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer.
Perelli L, Carbone F, Zhang L, Huang JK, Le C, Khan H, Citron F, Del Poggetto E, Gutschner T, Tomihara H, Soeung M, Minelli R, Srinivasan S, Peoples M, Lam TNA, Lundgren S, Xia R, Zhu C, Mohamed AMT, Zhang J, Sircar K, Sgambato A, Gao J, Jonasch E, Draetta GF, Futreal A, Bakouny Z, Van Allen EM, Choueiri T, Signoretti S, Msaouel P, Litchfield K, Turajlic S, Wang L, Chen YB, Di Natale RG, Hakimi AA, Giuliani V, Heffernan TP, Viale A, Bristow CA, Tannir NM, Carugo A, Genovese G. Perelli L, et al. Among authors: msaouel p. Nat Cancer. 2023 Jul;4(7):984-1000. doi: 10.1038/s43018-023-00584-1. Epub 2023 Jun 26. Nat Cancer. 2023. PMID: 37365326 Free PMC article.
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.
Jammihal T, Saliby RM, Labaki C, Soulati H, Gallegos J, Peris A, McCurry D, Yu C, Shah V, Poduval D, El Zarif T, El Ahmar N, Laimon YN, Eid M, Sheshdeh AB, Krajewski KM, Büttner FA, Schwab M, Heng D, Casellas RC, Rai K, Zacharias Millward NM, Msaouel P, Karam J, Signoretti S, Van Allen E, Choueiri TK, Braun DA, Shukla SA. Jammihal T, et al. Among authors: msaouel p. Nat Cancer. 2025 Feb;6(2):372-384. doi: 10.1038/s43018-024-00896-w. Epub 2025 Jan 9. Nat Cancer. 2025. PMID: 39789182 Free PMC article.
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
Vokshi BH, Davidson G, Tawanaie Pour Sedehi N, Helleux A, Rippinger M, Haller AR, Gantzer J, Thouvenin J, Baltzinger P, Bouarich R, Manriquez V, Zaidi S, Rao P, Msaouel P, Su X, Lang H, Tricard T, Lindner V, Surdez D, Kurtz JE, Bourdeaut F, Tannir NM, Davidson I, Malouf GG. Vokshi BH, et al. Among authors: msaouel p. Nat Commun. 2023 May 26;14(1):3034. doi: 10.1038/s41467-023-38472-y. Nat Commun. 2023. PMID: 37236926 Free PMC article.
264 results